[1]
“Enhanced Anti-Inflammatory Effects of Multicomponent Etoricoxib Formulations on TNF-α Suppression”, JPS, vol. 8, no. 4, pp. 2276–2284, Oct. 2025, doi: 10.36490/journal-jps.com.v8i4.1097.